Ireland· IE-PA-PA2299/027/001

Endoxana Injection 500 mg Powder for Solution for Injection

A cyclophosphamide product containing cyclophosphamide, registered in Ireland by Baxter Holding B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC L01AA01

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cyclophosphamideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cyclophosphamide is registered in 17 of 19 countries.

Countries holding a registration under ATC L01AA01 (cyclophosphamide), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
10 of them publish a price we can compare per daily dose

Search cyclophosphamide products by name

Cyclophosphamide · ATC L01AA01

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cyclophosphamide costs, country by country.

Normalised to the WHO defined daily dose (0.25 g), the median price runs from $1.57 in France to $14.12 in Switzerland — a ×9.0 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Cyclophosphamide · price per daily dose (0.25 g)

USD · FX 28 Sept 2026

CH Switzerland$14.12
IT Italy$1.58
FR France$1.57

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Cyclophosphamide
Manufacturer: Baxter Holding B.V.
Country: Ireland (IE)
ATC code: L01AA01
ATC class: Cyclophosphamide
Defined daily dose: 0.25 g, P
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
PA2299/027/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

541 interactions on record for cyclophosphamide.

Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cyclophosphamide against other medicines How interaction checks work

Cyclophosphamide · interactions on record

541 records

34 severe
172 moderate
29 minor
304 info

Most severe, free to view

Nalidixic acidJ01MB02severe
CidofovirJ05AB12severe
ThiotepaL01AC01severe
CladribineL01BB04severe

2 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cyclophosphamide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cyclophosphamide products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Cyclophosphamid Sandoz, Endoxan
Belgium · Cyclofosfamide Accord, Cyclophosphamide Hikma
Bulgaria · Cyclophosphamide Sandoz, Ендоксан
Cyprus · Cyclophosphamide Accord, Endoxan
Czechia · Cyclophosphamide Accord, Endoxan
Germany · Cyclophosphamid Accord, Cyclophosphamid Beta
Denmark · Cyclophosphamide Accord, Cyclophosphamide Sandoz
Estonia · Cyclophosphamide Accord, Endoxan
Spain · Ciclofosfamida Accord, Ciclofosfamida Dr. Reddy
Finland · Cyclophosphamide Accord, Sendoxan
France · Cyclophosphamide Accord, Cyclophosphamide Reddy Pharma
United Kingdom (Northern Ireland) · Cyclophosphamide Accord Healthcare, Cyclophosphamide Accord-Uk
Greece · Endoxan
Croatia · Ciklofosfamid Accord, Endoxan
Hungary · Endoxan
Iceland · Sendoxan
Italy · Ciclofosfamide Accord, Cyclophosphamide Monohydrate Seacross
Lithuania · Cyclophosphamide Accord Healthcare, Endoxan
Luxembourg · Endoxan
Latvia · Cyclophosphamide Accord, Endoxan
Malta · Endoxana, Endoxana Injection
Netherlands · Cyclofosfamide Accord, Cyclofosfamide Hikma
Norway · Cyclophosphamide Accord, Sendoxan
Poland · Cyclophosphamide Accord, Cyclophosphamide Sandoz
Portugal · Ciclofosfamida Accord, Ciclofosfamida Hikma
Romania · Ciclofosfamidă Accord, Ciclofosfamidă Dr. Reddy’s
Sweden · Cyclophosphamide Accord, Cyclophosphamide Sandoz
Slovenia · Endoxan
Slovakia · Endoxan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/9669c0c0-3b4e-41d8-862d-d41fda016451
GET /v1/drugs/9669c0c0-3b4e-41d8-862d-d41fda016451?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for injection",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "L01AA",
    "L01AA01"
  ],
  "strength": null,
  "pa_number": "PA2299/027/001",
  "substances": [
    "Cyclophosphamide"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "26/06/2008",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about cyclophosphamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console